Comment: Management of De Novo Chronic Myelogenous Leukemia and Imatinib-Induced Acute Rhabdomyolysis With the Second-Generation Tyrosine Kinase Inhibitor Dasatinib. (April 2016)

Record Type:: Journal Article
Title:: Comment: Management of De Novo Chronic Myelogenous Leukemia and Imatinib-Induced Acute Rhabdomyolysis With the Second-Generation Tyrosine Kinase Inhibitor Dasatinib. (April 2016)
Main Title:: Comment
Authors:: Uz, Burak
Dolasik, Ilhan
Abstract:
Is Part Of:: Annals of pharmacotherapy. Volume 50:Number 4(2016:Apr.)
Journal:: Annals of pharmacotherapy
Issue:: Volume 50:Number 4(2016:Apr.)
Issue Display:: Volume 50, Issue 4 (2016)
Year:: 2016
Volume:: 50
Issue:: 4
Issue Sort Value:: 2016-0050-0004-0000
Page Start:: 334
Page End:: 335
Publication Date:: 2016-04
Subjects:: Chemotherapy -- Periodicals
Pharmacology -- Periodicals
615.5805
Journal URLs:: http://theannals.com ↗
http://www.sagepublications.com/ ↗
DOI:: 10.1177/1060028015627663 ↗
Languages:: English
ISSNs:: 1060-0280
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store
Ingest File:: 6477.xml